Kwarlay.com

Navigating the News Maze with Clarity

Medicine

FDA Approves AOP Health’s Rapiblyk for Atrial Fibrillation and Atrial Flutter

Approval was based on the combined results from five studies of adults with supraventricular tachycardia.

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *